Literature DB >> 11704682

Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen.

Gloria A Di Lullo1, Shawn M Sweeney, Jarmo Korkko, Leena Ala-Kokko, James D San Antonio.   

Abstract

Type I collagen is the most abundant protein in humans, and it helps to maintain the integrity of many tissues via its interactions with cell surfaces, other extracellular matrix molecules, and growth and differentiation factors. Nearly 50 molecules have been found to interact with type I collagen, and for about half of them, binding sites on this collagen have been elucidated. In addition, over 300 mutations in type I collagen associated with human connective tissue disorders have been described. However, the spatial relationships between the known ligand-binding sites and mutation positions have not been examined. To this end, here we have created a map of type I collagen that includes all of its ligand-binding sites and mutations. The map reveals the existence of several hot spots for ligand interactions on type I collagen and that most of the binding sites locate to its C-terminal half. Moreover, on the collagen fibril some potentially relevant relationships between binding sites were observed including the following: fibronectin- and certain integrin-binding regions are near neighbors, which may mechanistically relate to fibronectin-dependent cell-collagen attachment; proteoglycan binding may potentially impact upon collagen fibrillogenesis, cell-collagen attachment, and collagen glycation seen in diabetes and aging; and mutations associated with osteogenesis imperfecta and other disorders show apparently nonrandom distribution patterns within both the monomer and fibril, implying that mutation positions correlate with disease phenotype. These and other observations presented here may provide novel insights into evaluating type I collagen functions and the relationships between its binding partners and mutations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704682     DOI: 10.1074/jbc.M110709200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  212 in total

Review 1.  The powerful functions of peptide-based bioactive matrices for regenerative medicine.

Authors:  Charles M Rubert Pérez; Nicholas Stephanopoulos; Shantanu Sur; Sungsoo S Lee; Christina Newcomb; Samuel I Stupp
Journal:  Ann Biomed Eng       Date:  2014-11-04       Impact factor: 3.934

2.  Prospects and limitations of the rational engineering of fibrillar collagens.

Authors:  Ireneusz Majsterek; Erin McAdams; Eijiro Adachi; Shirish T Dhume; Andrzej Fertala
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

3.  Influence of type I collagen surface density on fibroblast spreading, motility, and contractility.

Authors:  Christianne Gaudet; William A Marganski; Sooyoung Kim; Christopher T Brown; Vaibhavi Gunderia; Micah Dembo; Joyce Y Wong
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

4.  Amelogenin-collagen interactions regulate calcium phosphate mineralization in vitro.

Authors:  Atul S Deshpande; Ping-An Fang; James P Simmer; Henry C Margolis; Elia Beniash
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

5.  Conformational dynamics accompanying the proteolytic degradation of trimeric collagen I by collagenases.

Authors:  Arjun S Adhikari; Emerson Glassey; Alexander R Dunn
Journal:  J Am Chem Soc       Date:  2012-08-01       Impact factor: 15.419

6.  Mimicking the nanostructure of bone matrix to regenerate bone.

Authors:  Robert Kane; Peter X Ma1
Journal:  Mater Today (Kidlington)       Date:  2013-11-01       Impact factor: 31.041

Review 7.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

Review 8.  Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.

Authors:  Joan C Marini; Antonella Forlino; Wayne A Cabral; Aileen M Barnes; James D San Antonio; Sarah Milgrom; James C Hyland; Jarmo Körkkö; Darwin J Prockop; Anne De Paepe; Paul Coucke; Sofie Symoens; Francis H Glorieux; Peter J Roughley; Alan M Lund; Kaija Kuurila-Svahn; Heini Hartikka; Daniel H Cohn; Deborah Krakow; Monica Mottes; Ulrike Schwarze; Diana Chen; Kathleen Yang; Christine Kuslich; James Troendle; Raymond Dalgleish; Peter H Byers
Journal:  Hum Mutat       Date:  2007-03       Impact factor: 4.878

9.  Regulation of collagen fibrillogenesis by cell-surface expression of kinase dead DDR2.

Authors:  Angela R Blissett; Derek Garbellini; Edward P Calomeni; Cosmin Mihai; Terry S Elton; Gunjan Agarwal
Journal:  J Mol Biol       Date:  2008-10-30       Impact factor: 5.469

10.  Self-Assembly for the Synthesis of Functional Biomaterials.

Authors:  Nicholas Stephanopoulos; Julia H Ortony; Samuel I Stupp
Journal:  Acta Mater       Date:  2013-02-01       Impact factor: 8.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.